Introduction
Wertilin is a prescription medication that contains the active ingredient Betahistine. It is available in the form of extended-release tablets.
Uses
Wertilin is primarily prescribed to treat symptoms of Meniere’s disease, a condition that affects the inner ear. It helps alleviate symptoms such as vertigo (dizziness), tinnitus (ringing in the ears), and hearing loss associated with this condition.
Dosage and Administration
The dosage of Wertilin may vary depending on the severity of the symptoms and the individual patient’s response to the medication. Follow the instructions provided by your healthcare professional. Typically, the recommended dose for adults is one tablet taken twice daily with meals. The extended-release formulation allows for a prolonged release of the medication over time.
Mechanism of Action
Betahistine, the active ingredient in Wertilin, works by improving blood flow in the inner ear and reducing the pressure in the fluid-filled compartments. This is thought to help alleviate the symptoms of Meniere’s disease by restoring normal balance in the inner ear.
Side Effects
Common side effects may include headache, nausea, and stomach upset. These side effects are usually mild and transient.
Serious side effects are rare, but if you experience any of the following, seek medical attention immediately:
- Allergic reactions (e.g., rash, itching, swelling, difficulty breathing)
- Severe dizziness or fainting
- Chest pain or palpitations
Drug Interactions
Wertilin may interact with certain medications, potentially affecting their effectiveness or increasing the risk of side effects. Inform your healthcare professional about all the medications you are currently taking, including prescription, over-the-counter, and herbal products.
Some common drug interactions may include:
- Antihistamines
- Antidepressants
- Sedatives or tranquilizers
discuss potential drug interactions with your healthcare professional before starting Wertilin.
Precautions
Before taking Wertilin, inform your healthcare professional about any existing medical conditions, including allergies, liver or kidney problems, or any other significant health issues.
Wertilin should not be used in individuals with pheochromocytoma, a rare tumor of the adrenal gland, as it may worsen the symptoms.
Additionally, Wertilin may interact with alcohol or medications that cause drowsiness. It is advisable to avoid alcohol and exercise caution while operating machinery or performing tasks that require alertness.
Storage
Wertilin should be stored at room temperature, away from direct sunlight and moisture. Keep the medication out of reach of children and pets. Do not use the medication if it has exceeded its expiration date.
Patient Tips
- Take Wertilin exactly as prescribed by your healthcare professional.
- It may take some time for the medication to show its full effect. Be patient and continue taking it as directed.
- If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.
- Do not exceed the prescribed dosage. Taking more than the recommended amount may increase the risk of side effects.
- If you have any concerns or questions about the medication, do not hesitate to consult your healthcare professional. They are best equipped to address your specific needs and provide appropriate guidance.
Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.
References
- Betahistine: a medicine to treat Ménière’s disease (NHS UK) [Accessed 12 Jun. 2024] (online) Available at:
- Betahistine 16 mg tablets (Health Professionals SmPC) Available at:
- Betahistine dihydrochloride (International database) (Drugs.com) [Accessed 22 Jun. 2024] (online) Available at:
- Medication (for Vestibular Disorders) (Vestibular Disorders Association) [Accessed 23 Jun. 2024] (online) Available at:
- Murdin L, Hussain K, Schilder AG. Betahistine for symptoms of vertigo. Cochrane Database Syst Rev. 2016 Jun 21;2016(6):CD010696. doi: 10.1002/14651858.CD010696.pub2. [Accessed 25 Jun. 2024] Available at:
Reviews
There are no reviews yet.